Palantir's stock fell for a fifth-straight day after touching new highs earlier this month. The artificial intelligence software provider had a stellar earnings report earlier this month, reporting its first-ever $1 billion revenue quarter.
Palantir (PLTR) shares tumbled Tuesday afternoon, extending recent losses as a high-profile short seller fueled worries the stock could be overvalued after a strong run earlier this year.
Get Forbes Breaking News Text Alerts: We're launching text message alerts so you'll always know the biggest stories shaping the day's headlines. Text “Alerts” to (201) 335-0739 or sign up here.
Palantir's $420B valuation, soaring 130% this year, tests limits with sky-high multiples and lofty performance expectations.
Palantir's Q2 results show accelerating growth and margins, making its high valuation more justifiable based on both narrative and cash flow potential. The company excels by the Rule of 40, with a 94% score and raised guidance suggesting over 50% YoY growth for the full year. But Palantir's reliance on sensitive data could limit its total addressable market. Not just for government contracts but also commercial revenues.
Tuesday marks the fifth consecutive trading day shares have dropped.
Andrew Left argues that investors have overhyped Palantir stock, and its valuation pales in comparison to a true AI leader like OpenAI.
Palantir Technologies Inc. (PLTR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Palantir (NASDAQ: PLTR) shares slid on Monday after short seller Citron Research escalated its criticism of the company, warning that even at significantly lower levels, the stock remains overvalued.
Shares of Palantir Technologies Inc. (NASDAQ:PLTR) lost 5.06% over the past five trading sessions.
The network connects founders and venture capitalists with ‘Palantir Pals' and a Russian River camping trip
I initiate Big Bear Holdings with a Hold. Management cut FY revenue guidance by 22% to $125–$140M, missed revenue by $10.8M in Q2 on federal contract disruptions, and withdrew full year EBITDA guidance. OB3 could aid ConductorOS and Shipyard AI, but I'm not seeing lift for biometrics. I'd rather wait for a ramp in DoD contracts, even if that means paying a premium.